Literature DB >> 2321322

Analysis of neurologic symptoms in deep diving: implications for selection of divers.

K Todnem1, H Nyland, T Riise, B K Kambestad, R Vaernes, J O Hjelle, R Svihus, J A Aarli.   

Abstract

Eighteen professional divers (age range 24-33 yr, mean 28.3) participated in one simulated dive to 360 meters of seawater (msw) in a helium-oxygen (heliox) atmosphere with equal compression and decompression profiles. All divers were given an extensive neurologic examination before diving. Clinical neurologic symptoms observed during the dives were equilibrium disorder, sleep disturbances, fatigue, nausea, loose stools, stomach pain, tremor, mental disturbances, reduced appetite, and headache. Symptoms were scored individually by each diver. The symptoms were analyzed statistically by factor analysis, which grouped them into four factors. These symptoms are presumably related to functional disturbances in the brain stem and the cerebellum. Factor 3 symptoms (tremor, mental disturbances, reduced appetite) correlated significantly to a history of predive decompression sickness (P = 0.006) and to cerebral concussion (P = 0.023). Three divers were periodically unable to work at bottom due to equilibrium disorder, diarrhea, or nausea. One diver with mild polyneuropathy and slight cerebral atrophy as seen by computerized tomography and another diver with abnormal electroencephalography were periodically unable to work due to equilibrium disorder and nausea, respectively. We advocate that divers with signs of central or peripheral nervous system dysfunction should not be selected for deep diving.

Entities:  

Mesh:

Year:  1990        PMID: 2321322

Source DB:  PubMed          Journal:  Undersea Biomed Res        ISSN: 0093-5387


  2 in total

1.  Neurological long term consequences of deep diving.

Authors:  K Todnem; H Nyland; H Skeidsvoll; R Svihus; P Rinck; B K Kambestad; T Riise; J A Aarli
Journal:  Br J Ind Med       Date:  1991-04

2.  [Hearing impairment in divers].

Authors:  C Klingmann; P K Plinkert
Journal:  HNO       Date:  2005-12       Impact factor: 1.284

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.